- Home
- MNSB vs DTIL Comparison
MNSB vs DTIL Comparison
Compare MNSB & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNSB | DTIL |
|---|---|---|
| Founded | 2003 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 140.1M | 115.5M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | MNSB | DTIL |
|---|---|---|
| Price | $21.72 | $4.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $47.00 |
| AVG Volume (30 Days) | 39.7K | ★ 182.5K |
| Earning Date | 01-26-2026 | 11-03-2025 |
| Dividend Yield | ★ 1.84% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $69,367,000.00 | $698,000.00 |
| Revenue This Year | $23.19 | N/A |
| Revenue Next Year | $2.92 | $34.30 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 9.71 | N/A |
| 52 Week Low | $15.00 | $3.61 |
| 52 Week High | $22.98 | $8.82 |
Technical Indicators
Market Signals| Indicator | MNSB | DTIL |
|---|---|---|
| Relative Strength Index (RSI) | 79.36 | 40.56 |
| Support Level | $19.68 | $4.67 |
| Resistance Level | $21.44 | $5.20 |
| Average True Range (ATR) | 0.49 | 0.34 |
| MACD | 0.23 | 0.03 |
| Stochastic Oscillator | 89.08 | 24.32 |
Price Performance
Historical ComparisonAbout MNSB MainStreet Bancshares Inc.
MainStreet Bancshares Inc is a bank holding company. It is focused on serving the borrowing, cash management and depository needs of small to medium-sized businesses, and professional practices and retail customers. The bank's products and services include business and consumer checking, premium interest-bearing checking, business account analysis, savings, certificates of deposit and other depository services, as well as a broad array of commercial, real estate and consumer loans.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.